Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot P17813: Variant p.Met269Arg

Endoglin
Gene: ENG
Feedback?
Variant information Variant position: help 269 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance
Residue change: help From Methionine (M) to Arginine (R) at position 269 (M269R, p.Met269Arg). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from medium size and hydrophobic (M) to large size and basic (R) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help -1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page
Variant description: help In HHT1. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 269 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 658 The length of the canonical sequence.
Location on the sequence: help AVLILQGPPYVSWLIDANHN M QIWTTGEYSFKIFPEKNIRG The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences. 
Human                         AVLILQGPPYVSWLIDANHNMQIWTTGEYSFKIFPEKNIRG

Mouse                         AILILHGPPYVSWFIDINHSMQILTTGEYSVKIFPGSKVKG

Pig                           AVLILQGPPYVSWLIDANHNVKAWTTGEYSFKIFPGSNIQG

Zebrafish                     --VVLRGPAGTHWIIKNSLRIGILSNNQIHLQSFPLR--PR
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 26 – 658 Endoglin
Topological domain 26 – 586 Extracellular
Region 26 – 337 Required for interaction with GDF2
Region 200 – 330 OR1, C-terminal part
Disulfide bond 242 – 330
Mutagenesis 269 – 269 M -> A. Impairs protein folding, but does not abolish interaction with GDF2.
Mutagenesis 277 – 277 Y -> A. No effect on interaction with GDF2.
Mutagenesis 278 – 278 S -> P. Loss of interaction with GDF2.
Mutagenesis 282 – 282 F -> V. Loss of interaction with GDF2.



Literature citations
Update on molecular diagnosis of hereditary hemorrhagic telangiectasia.
Richards-Yutz J.; Grant K.; Chao E.C.; Walther S.E.; Ganguly A.;
Hum. Genet. 128:61-77(2010)
Cited for: VARIANTS PRO-150; PRO-205; MET-236; MET-315; GLU-374; ARG-414; SER-545; TYR-549 AND ALA-561; VARIANTS HHT1 GLN-221; GLU-238; SER-263; ARG-269; TYR-394; PRO-529 AND ARG-603;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.